SOPHiA GENETICS (NASDAQ: SOPH) maintains a market capitalization of approximately $710 million to $735 million, trading at a share price hovering near $8.65. Its total enterprise valuation fluctuates continuously during active market sessions based on trading volume, quarterly financial disclosures, and shifts in sentiment toward small-cap health-tech equities.